Zenas Z N Yiu

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Richard B. Warren, Catherine Smith, Zenas Z N Yiu et al. · Journal of Investigative Dermatology · 2015 · 366 citations

British Association, Clinical Epidemiology, Clinical Dermatology +6

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017

Catherine Smith, Zarif K. Jabbar‐Lopez, Zenas Z N Yiu et al. · British Journal of Dermatology · 2017 · 257 citations · Full text

Language Documentation, British Association, Lexical Resource +13

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update

Catherine Smith, Zenas Z N Yiu, Tracy Bale et al. · British Journal of Dermatology · 2020 · 220 citations · Full text

Language Documentation, Allergy, Medicine +8

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Satveer K. Mahil, Nick Dand, K.J. Mason et al. · Journal of Allergy and Clinical Immunology · 2020 · 158 citations · Full text

Adverse Covid-19 Outcomes, Global Health, Covid-19 Pandemic +9

Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis

Zenas Z N Yiu, G Becher, Brian Kirby et al. · JAMA Dermatology · 2022 · 136 citations · Full text